Clinical Trial: Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553468) titled 'Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy' on April 22.

Brief Summary: This is an interventional open-label study to determine the safety and clinical performance of SVF cells in the treatment of Diabetic Peripheral Neuropathy.

Study Start Date: Dec. 01, 2024

Study Type: INTERVENTIONAL

Condition: Diabetic Foot Diabetic Peripheral Neuropathy

Intervention: BIOLOGICAL: Adipose-derived Stromal Vascular Fraction Cells

Administration to the DFU / ankle was performed at four injection sites:

1. 20 cc into the wound bed

2. 20 cc subcutaneously around the perimeter of the wound

3. 10 cc along the t...